FindTrial
Sign In

Effects of dexmedetomidine on traumatic brain injury

Study of effects of dexmedetomidine on traumatic brain injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17010565
Enrollment
Unknown
Registered
2017-02-07
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic brain injury

Interventions

Experimental group:Use dexmedetomidine
Control group:No dexmedetomidine

Sponsors

Kunshan Hospital Affiliated with Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged 18-70 years; suffered TBI and admission GCS 6-15

Exclusion criteria

Exclusion criteria: Admission GCS 6-15; Coagulopathy; History of drug allergy; Hypertension and cardiovascular diseases; Liver and kidney dysfunction; Diabetes; Hypovolemia; Taking sedatives in recent 2 days; Sinus bradycardia or conduction disturbance; Pupil dilated after surgery, or vital signs unstable.

Design outcomes

Primary

MeasureTime frame
BP;HR;SPO2;RASS score;Hematoma and edema volume;GOS;ADL;—

Countries

China

Contacts

Public ContactShuguang Zhang

Kunshan Hospital Affiliated with Jiangsu University

sl1012002322@126.com+86 137731762221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026